Accretion Pharmaceuticals Limited (NSE:ACCPL)
India · Delayed Price · Currency is INR 67.45
-3.50 (-4.93%)
At close: Mar 5, 2026
Accretion Pharmaceuticals Market Cap
Accretion Pharmaceuticals has a market cap or net worth of 749.77 million as of March 5, 2026.
Market Cap
749.77M
Enterprise Value
826.77M
Revenue
826.43M
Ranking
n/a
PE Ratio
6.87
Stock Price
67.45
Market Cap Chart
Since May 21, 2025, Accretion Pharmaceuticals's market cap has decreased from 922.07M to 749.77M, a decrease of -18.69%. That is a compound annual growth rate of -23.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 749.77M | -23.22% |
| Dec 31, 2025 | 976.54M | 5.91% |
| May 21, 2025 | 922.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Concord Drugs | 962.04M |
| Mercury Laboratories | 950.76M |
| Makers Laboratories | 884.76M |
| Source Natural Foods and Herbal Supplements | 836.80M |
| Asston Pharmaceuticals | 674.65M |
| Amwill Health Care | 668.72M |
| Onyx Biotec | 591.11M |
| Godavari Drugs | 581.88M |